Abstract: The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.

Abstract: The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.

Abstract: A system for a semiconductor fabrication facility comprises a transporting tool configured to move a carrier, a first manufacturing tool configured to accept the carrier facing in a first direction, a second manufacturing tool configured to accept the carrier facing in the second direction, and an orientation tool. The carrier is moved to the orientation tool by the transporting tool prior to being moved to the first manufacturing tool or the second manufacturing tool by the transporting tool. The orientation tool rotates the carrier so that the carrier is accepted by the first manufacturing tool or the second manufacturing tool. The transporting tool, the first manufacturing tool, the second manufacturing tool and the orientation tool are physically separated from each other.

Abstract: A shutdown criterion is determined to be met with respect to a cluster. Responsive to determining that the shutdown criterion is met, a request router is configured to route requests addressed to the cluster to a destination that indicates that the cluster is unavailable. A request to shut down the cluster is transmitted. A request to start the cluster is received. The request is initiated via the destination that indicates that the cluster is unavailable. In response to receiving the request to start the cluster, the cluster is started and the request router is configured to direct, to the cluster, requests addressed to the cluster.

Abstract: A system for a semiconductor fabrication facility (FAB) includes an orientation tool and a transporting tool configured to transport at least one customized part. The orientation tool includes a port configured to receive the workpiece, a sensor configured to detect an orientation of the workpiece received in the port and a rotation mechanism configured to turn the workpiece received in the port.

Abstract: Described are apparatus, systems, and methods that are operable to conserve battery power of a wearable device by monitoring a state of the user wearing the wearable device and adjusting power state of one or more components of the device based on the determined user state and/or altering a wireless transmission of sensor data collected by the wearable device from the wearable device to a portable device associated with the user. For example, if it is determined that the user is in a sleep state, the wireless connection between the wearable device and the portable device may be terminated, the wireless transmitter and the processor transitioned to a low power state, and sensor data stored in a buffer memory of the wearable device until a defined period of time before the user exits the sleep state and/or upon satisfaction of a buffer usage threshold.

Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a mixture of a triglyceride of ricinoleic acid and a gelling agent, in a formulation with loteprednol, latanoprost, celecoxib, triamcinolone, or betamethasone and, optionally, a second corticosteroid, analgesic, or anti-inflammatory agent.

Abstract: Devices, systems, and methods are provided for gesture-based selections of devices. A method may include receiving, by at least one processor of a first device, an input associated with causing a second device to perform an action. The method may include identifying motion data associated with the first device. The method may include determining, based on the motion data, a gesture associated with the first device. The method may include receiving an indicator from the second device and determining, based on the indicator, that the gesture is associated with selecting the second device to perform the action. The method may include sending a command to the second device, the command associated with causing the second device to perform the action.

Abstract: The invention relates to Cu-embedded masterbatches forming by a novel formulation and its production process. The novel formulation comprises a mixing powder prepared from Cu2O and ZnO. The mixing powder is milled in water to form slurry. Spray-dry the slurry at 130˜150° C. to get anti-bacterial powder. Add 12 wt. %˜15 wt. % of the anti-bacterial powder to plastic masterbatches and follow by pre-mixing, heating, stirring, melting, extruding, cooling and cutting process to obtain the Cu-embedded masterbatches.

Abstract: The present invention relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection.

Abstract: An example operation may include one or more of receiving a plurality of transactions by an agent node, selecting, by the agent node, transactions from the plurality of the transactions that are the most likely to be conflicting based on common factors, combining, by the agent node, the selected transactions into a batch, and reordering the selected transactions within the batch to increase a success rate.

Abstract: A system for a semiconductor fabrication facility (FAB) and operation method thereof are provided. The system includes an orientation tool and a transporting tool configured to transport at least one customized part. The orientation tool includes a port configured to receive the workpiece, a sensor configured to detect an orientation of the workpiece received in the port and a rotation mechanism configured to turn the workpiece received in the port.

Abstract: An example operation may include one or more of submitting, by a blockchain client, a transaction proposal to a blockchain network, endorsing, by one or more endorser nodes or peers, the transaction proposal, endorsing comprising updating an in-process world state list, providing one or more composite endorsements, each comprising a base result and a forecasted result corresponding to the transaction proposal, submitting an endorsed transaction in response to the one or more composite endorsements, validating, by a committer node or peer, the endorsed transaction, committing the endorsed transaction to the blockchain network, and removing the committed transaction from the in-process world state list.

Abstract: An example operation may include one or more of receiving a plurality of transactions by an agent node, selecting, by the agent node, transactions from the plurality of the transactions that are the most likely to be conflicting based on common factors, combining, by the agent node, the selected transactions into a batch, and reordering the selected transactions within the batch to increase a success rate.

Abstract: Smart television signal source-based method for displaying floating menu and smart television, comprising: calling floating menu to any position on current page when receiving signal source forced to be broadcast; floating menu acquiring signal source channel, and, according to system file configuration, acquiring configuration entries requiring display by current smart television model, before displaying on current page; configuration entries automatically undergoing dynamic sorting according to current system status.

Abstract: A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Abstract: A backlight adjustment method and a backlight adjustment system are provided. The backlight adjustment method includes a compensation phase. The compensation phase includes: controlling a light source to respectively emit light having a plurality of first illuminations; detecting a plurality of backlight parameters of a display device under the light having the plurality of first illuminations, and calculating a brightness compensation coefficient of the display device according to the plurality of backlight parameters; and adjusting a backlight coefficient of the display device according to the brightness compensation coefficient, so as to compensate for backlight brightness of the display device.

Abstract: A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Abstract: An example operation may include one or more of submitting, by a blockchain client, a transaction proposal to a blockchain network, endorsing, by one or more endorser nodes or peers, the transaction proposal, endorsing comprising updating an in-process world state list, providing one or more composite endorsements, each comprising a base result and a forecasted result corresponding to the transaction proposal, submitting an endorsed transaction in response to the one or more composite endorsements, validating, by a committer node or peer, the endorsed transaction, committing the endorsed transaction to the blockchain network, and removing the committed transaction from the in-process world state list.

Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a mixture of a triglyceride of ricinoleic acid and a gelling agent, in a formulation with loteprednol, latanoprost, celecoxib, triamcinolone, or betamethasone and, optionally, a second corticosteroid, analgesic, or anti-inflammatory agent.